Tredje AP-fonden »

Halozyme Therapeutics shares owned by Tredje AP-fonden

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Tredje AP-fonden from 13F filings

Historical chart of Tredje AP-fonden investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Tredje AP-fonden consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Tredje AP-fonden

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.0M 30k 67.30

More positions owned by Tredje AP-fonden

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Franklin Templeton Etf Tr Systmtc Styl Pre (FLSP)
Mastercard Incorporated Cl A (MA)
Amplify Etf Tr Blackswan Grwt (SWAN)
New York Life Investments Et Nyli Hedge Multi (QAI)
Alphabet Cap Stk Cl C (GOOG)
Abbvie (ABBV)

View all positions for Tredje AP-fonden

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Alliancebernstein
Norges Bank Investment Management
William Blair Investment Management
Federated Investors
Jupiter Asset Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics